Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.7 HKD | -1.55% | -0.18% | -15.30% |
Apr. 25 | Simcere Pharmaceutical’ Profit Down 23% in 2023 | MT |
Apr. 10 | Simcere Pharmaceutical's Cancer Drug Gets Fast Track Designation From US FDA | MT |
Sales 2024 * | 1.03B 8.07B | Sales 2025 * | 1.2B 9.38B | Capitalization | 1.87B 14.6B |
---|---|---|---|---|---|
Net income 2024 * | 141M 1.1B | Net income 2025 * | 180M 1.41B | EV / Sales 2024 * | 1.54 x |
Net cash position 2024 * | 281M 2.19B | Net cash position 2025 * | 367M 2.87B | EV / Sales 2025 * | 1.25 x |
P/E ratio 2024 * |
13.6
x | P/E ratio 2025 * |
10.6
x | Employees | 7,027 |
Yield 2024 * |
2.57% | Yield 2025 * |
3.2% | Free-Float | 28.7% |
1 day | -1.55% | ||
1 week | -0.18% | ||
Current month | +5.56% | ||
1 month | +8.99% | ||
3 months | +7.34% | ||
6 months | -21.49% | ||
Current year | -15.30% |
Managers | Title | Age | Since |
---|---|---|---|
Jin Sheng Ren
CEO | Chief Executive Officer | 61 | 94-12-31 |
Yu Shan Wan
DFI | Director of Finance/CFO | 53 | 00-04-30 |
Gaobo Zhou
CIO | Chief Investment Officer | 45 | 22-01-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jin Sheng Ren
CEO | Chief Executive Officer | 61 | 94-12-31 |
Xin Hua Wang
BRD | Director/Board Member | 69 | 19-11-18 |
Yu Shan Wan
DFI | Director of Finance/CFO | 53 | 00-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.22% | 4 M€ | -27.92% | ||
0.24% | 2 M€ | -14.14% | ||
0.01% | 112 M€ | +4.91% | - | |
0.00% | 45 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 5.7 | -1.55% | 8,174,000 |
24-05-13 | 5.79 | -0.52% | 6,968,363 |
24-05-10 | 5.82 | +0.34% | 7,893,000 |
24-05-09 | 5.8 | +0.87% | 7,244,100 |
24-05-08 | 5.75 | +0.70% | 4,211,000 |
Delayed Quote Hong Kong S.E., May 14, 2024 at 04:08 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.30% | 1.9B | |
+22.69% | 43.81B | |
+24.86% | 23.01B | |
+18.00% | 15.27B | |
+8.91% | 13.68B | |
+42.72% | 11.96B | |
-7.15% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.22% | 5.59B |
- Stock Market
- Equities
- 2096 Stock